Skip to main content
Hongying Liao on Muck Rack

Hongying Liao

As seen in: Nature, McKinsey & Company
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hongying

Contact Hongying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Synergistic effects of pigments, morphology, and physio-biochemical parameters reveal petal coloration differences in eight rose cultivars

|
By Xiaoyu Gao, Hongying Liao, Tian Xu, Lurong Pan, Ting Xu, Tinghui Yin, Shu Xiang Li, Weichao Teng, Xianglu Jia, Quanguang Yang, Miaoqin Wei, Zilong Ouyang
| Nature Verified
Abstract As a key ornamental plant, the core value of rose (Rosa spp.) resides in its petals. Variations in petal development and physio-biochemical parameters among cultivars exhibiting divergent floral coloration could significantly influence their horticultural performance and commercial viability.
Open in Who Shared Issue with article?

PHKG2 confers resistance of ESCC to cisplatin and enhances CXCL8-dependent immunosuppression to exacerbate tumorigenesis

|
By Jiayan Wu, Haosheng Zheng, Fei Qin, Yuzhen Zheng, Junguo Chen, Zui Liu, Xingping Yang, Guolin Li, Hongying Liao, Chengrui Zhong, Xianyu Qin, Gengfeng Wang, Bozhu Jian
| Nature Verified
Abstract Cisplatin (DDP)-based chemotherapy serves as a foundational cornerstone in the clinical management of esophageal squamous cell carcinoma (ESCC). However, intrinsic or acquired resistance to DDP persists as a significant clinical challenge, severely undermining therapeutic efficacy and contributing to unfavorable patient prognoses.
Open in Who Shared Issue with article?

Primary tumor resection might improve outcomes in metastatic thoracic esophageal cancer - Scientific Reports

|
By Hongying Liao
| Nature Verified
Abstract The study aims to evaluate the survival impact of primary tumor resection (PTR) on thoracic esophageal cancer with distant metastasis(TECDM). Data of patients with TECDM was collected from the Surveillance, Epidemiology, and End Results database(SEER) from 2010 to 2020. A 1:1 propensity-score matching(PSM) analysis was employed to minimize heterogeneity between the groups.
Open in Who Shared Issue with article?
See all 4 articles